Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-23

Clinical Trial Update: Atazanavir and Lamivudine for Treatment Simplification [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating simplification of HIV therapy to a fixed-dose combination of atazanavir/lamivudine; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)
  • REYATAZ (atazanavir)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2015-02-23